280
Participants
Start Date
December 31, 2025
Primary Completion Date
May 31, 2029
Study Completion Date
November 30, 2029
Therapeutic Drug Monitoring for Linezolid
TDM with dose adjustment for trough concentration \>2.5 mg/L LZD
Nkqubela TB Specialist Hospital, East London
University of Cape Town
OTHER
St George's, University of London
OTHER
Emory University
OTHER
National Department of Health, South Africa
UNKNOWN
Columbia University
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Albert Einstein College of Medicine
OTHER